DDrare: Database of Drug Development for Rare Diseases

Searched query = "Spinocerebellar degeneration", "SCD", "Spinocerebellar ataxia type I", "SCA1", "Spinocerebellar ataxia type II", "SCA2", "Spinocerebellar ataxia type III", "SCA3", "Machado-Joseph disease", "Spinocerebellar ataxia type VI", "SCA6", "Spinocerebellar ataxia type VII", "SCA7", "Spinocerebellar ataxia type X", "SCA10", "Spinocerebellar ataxia type XII", "SCA12", "Dentatorubural pallidoluysian atrophy", "Dentatorubropallidoluysial atrophy", "DRPLA", "Naito-Koyanagi disease", "Friedreich ataxia", "FRDA", "Ataxia with vitamin E deficiency", "AVED", "Early-onset ataxia with ocular motor ataxia and hypoalbuminemia", "EOAH"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = BINOCRIT*1SIR 40000UI/1ML; Baclofen; Bupropion; Bupropion & Citalopram; Butylphthalide; C-Trelin OD Tab(5mg Taltirelin Hydrate); CTI-1601; Cabaletta; Cabaletta for IV infusion once weekly during 24 weeks; Carbonate; Citalopram; Coenzyme Q10; Deferiprone; EGB 761 (r) 120 mg; EGb 761 120 mg; EPOETIN ALFA; EPREX*1FL 40000UI/ML 1ML; EPREX*1SIR 10000UI 1ML; EPREX*1SIR 40000UI/ML 1ML; EU1/97/031-032; EU1/97/031/031-032; Epoeitin beta; Epoetin alfa; Erythropoietin; Etravirine; Etravirine Tablets; Flumazenil; Gamma interferon; Ginkgo; Ginkgo biloba; Granocyte; H-116PI-DE.pdf; High-dose intravenous immunoglobulin (IVIG); IMUKIN*SC 6F 0,5ML 100MCG; INTERFERON GAMMA-1B; Idebenone; Interferon Gamma; Interferon Gamma-1b; Interferon gamma-1b; Iron; Iron chelating intervention; KPS-0373; KPS-0373, High dose; KPS-0373, Low dose; Lenograstim; Lithium Carbonate; Lithium carbonate; Lu AA24493; MIN-102; Methylprednisolone; NICOTINAMIDE; Neo-Recormon; Neorecormon; Nicotinamide; Nicotinamide Riboside; Nicotinamide riboside; Omaveloxolone; Omaveloxolone Capsules, 10 mg; Omaveloxolone Capsules, 150 mg; Omaveloxolone Capsules, 160 mg; Omaveloxolone Capsules, 2.5 mg; Omaveloxolone Capsules, 20 mg; Omaveloxolone Capsules, 300 mg; Omaveloxolone Capsules, 40 mg; Omaveloxolone Capsules, 5 mg; Omaveloxolone Capsules, 80 mg; Other: Exercise Intervention; RHuG-CSF; Resveratrol; Riluzole; Riluzole PMCS; Rokan (r) Novo 120 mg; Rosuvastatin; SUB09246MIG; Standardized Ginkgo Biloba Extract (EGb 761 (r); TAK-831; Varenicline; Vatiquinone

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Countries
1	EUCTR2008-003662-25-IT (EUCTR)	21/10/2009	01/10/2009	Studio randomizzato, in doppio cieco, controllato verso placebo, per valutare la sicurezza e la tollerabilita` e per esplorare l efficacia di Lu AA24493, in pazienti con Atassia di Friedreich - ND	Studio randomizzato, in doppio cieco, controllato verso placebo, per valutare la sicurezza e la tollerabilita` e per esplorare l efficacia di Lu AA24493, in pazienti con Atassia di Friedreich - ND	Friedreich`s Ataxia (FRDA) MedDRA version: 9.1;Level: LLT;Classification code 10017374	Product Name: Lu AA24493 Product Code: Lu AA24493	H.Lundbeck A/S	NULL	Not Recruiting	Female: yes Male: yes	36	Germany;Italy;Austria
2	EUCTR2008-003662-25-AT (EUCTR)	02/10/2009	14/08/2009	Randomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacy	Randomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacy	Friedreich's Ataxia (FRDA) MedDRA version: 12.0;Level: LLT;Classification code 10017374;Term: Friedreich's ataxia	Product Name: Lu AA24493 Product Code: Lu AA24493	H. Lundbeck A/S	NULL	Not Recruiting	Female: yes Male: yes	36	Germany;Italy;Austria
3	EUCTR2008-003662-25-DE (EUCTR)		21/08/2009	Randomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacy	Randomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacy	Friedreich's Ataxia (FRDA) MedDRA version: 12.0;Level: LLT;Classification code 10017374;Term: Friedreich's ataxia	Product Name: Lu AA24493 Product Code: Lu AA24493	H. Lundbeck A/S	NULL	Not Recruiting	Female: yes Male: yes	36	Austria;Germany;Italy

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

EUCTR2008-003662-25-IT
(EUCTR)

21/10/2009

01/10/2009

Studio randomizzato, in doppio cieco, controllato verso placebo, per valutare la sicurezza e la tollerabilita` e per esplorare l efficacia di Lu AA24493, in pazienti con Atassia di Friedreich - ND

Friedreich`s Ataxia (FRDA)
MedDRA version: 9.1;Level: LLT;Classification code 10017374

Product Name: Lu AA24493
Product Code: Lu AA24493

H.Lundbeck A/S

NULL

Not Recruiting

Female: yes
Male: yes

Germany;Italy;Austria

EUCTR2008-003662-25-AT
(EUCTR)

02/10/2009

14/08/2009

Randomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacy

Friedreich's Ataxia (FRDA)
MedDRA version: 12.0;Level: LLT;Classification code 10017374;Term: Friedreich's ataxia

Product Name: Lu AA24493
Product Code: Lu AA24493

H. Lundbeck A/S

NULL

Not Recruiting

Female: yes
Male: yes

Germany;Italy;Austria

EUCTR2008-003662-25-DE
(EUCTR)

21/08/2009

Randomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacy

Friedreich's Ataxia (FRDA)
MedDRA version: 12.0;Level: LLT;Classification code 10017374;Term: Friedreich's ataxia

Product Name: Lu AA24493
Product Code: Lu AA24493

H. Lundbeck A/S

NULL

Not Recruiting

Female: yes
Male: yes

Austria;Germany;Italy